SWP
HQL

Stratos Wealth Partners’s abrdn Life Sciences Investors HQL Stock Holding History

Stratos Wealth Partners’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Sell
11,660
-4,444
-28% -$78.5K ﹤0.01% 1546
2026
Q1 		$262K Buy
16,104
+980
+6% +$16.4K ﹤0.01% 1397
2025
Q4 		$254K Hold
15,124
– – ﹤0.01% 1385
2025
Q3 		$235K Buy
15,124
+465
+3% +$6.37K ﹤0.01% 1378
2025
Q2 		$188K Buy
14,659
+483
+3% +$5.96K ﹤0.01% 1348
2025
Q1 		$180K Buy
14,176
+971
+7% +$13.1K ﹤0.01% 1292
2024
Q4 		$173K Hold
13,205
– – ﹤0.01% 1371
2024
Q3 		$199K Buy
13,205
+408
+3% +$6.17K ﹤0.01% 1345
2024
Q2 		$181K Buy
12,797
+433
+4% +$5.86K ﹤0.01% 1280
2024
Q1 		$169K Buy
12,364
+614
+5% +$8.49K ﹤0.01% 1299
2023
Q4 		$158K Hold
11,750
– – ﹤0.01% 1296
2023
Q3 		$147K Buy
11,750
+294
+3% +$3.87K ﹤0.01% 1202
2023
Q2 		$155K Buy
11,456
+258
+2% +$3.56K ﹤0.01% 1118
2023
Q1 		$156K Sell
11,198
-9
-0.1% -$129 ﹤0.01% 1059
2022
Q4 		$159K Buy
11,207
+232
+2% +$3.36K ﹤0.01% 1065
2022
Q3 		$150K Sell
10,975
-161
-1% -$2.41K ﹤0.01% 1051
2022
Q2 		$158K Buy
11,136
+673
+6% +$10.2K ﹤0.01% 1109
2022
Q1 		$173K Buy
10,463
+247
+2% +$4.25K ﹤0.01% 1193
2021
Q4 		$196K Buy
10,216
+216
+2% +$4.35K ﹤0.01% 1179
2021
Q3 		$208K Buy
10,000
+196
+2% +$4.2K 0.01% 1086
2021
Q2 		$210K Buy
+9,804
New +$198K 0.01% 1103
2018
Q4 		– Sell
-830
Closed -$17K – 1559
2018
Q3 		$17K Buy
+830
New +$16.5K ﹤0.01% 1953
2018
Q2 		– Sell
-798
Closed -$15K – 1684
2018
Q1 		$15K Buy
798
+16
+2% +$320 ﹤0.01% 2129
2017
Q4 		$15K Buy
+782
New +$15.7K ﹤0.01% 1999

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Stratos Wealth Partners's HQL Position: Q2 2026 in Review

Stratos Wealth Partners reduced its abrdn Life Sciences Investors (HQL) stake by 28% in Q2 2026, selling an estimated $78.5K and leaving 11,660 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Stratos Wealth Partners first reported a position in HQL in Q4 2017 and has held it in 24 quarters since. The position peaked at $262K in Q1 2026. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Stratos Wealth Partners held 11,660 shares of abrdn Life Sciences Investors worth $233K as of Q2 2026.
  • Stratos Wealth Partners sold 4,444 abrdn Life Sciences Investors shares in Q2 2026, an estimated $78.5K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #1546 holding.
  • Stratos Wealth Partners first reported a position in abrdn Life Sciences Investors in Q4 2017 and has held it in 24 quarters since.
  • Stratos Wealth Partners's abrdn Life Sciences Investors position peaked at $262K in Q1 2026.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.